The volume of information attendees receive at the annual Transcatheter Cardiovascular Therapeutics (TCT) interventional ...
In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore ...
September 7, 2018 — The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival ...
September 6, 2018 — Tafamidis is the first treatment to improve survival and reduce hospitalizations in a rare heart ...
September 6, 2018 — While it is firmly established that the use of one internal thoracic artery can improve life ...
September 5, 2018 — Aspirin prevented serious vascular events in patients with diabetes who did not already have ...
September 4, 2018 — The jury is still out on whether people at moderate risk of a first heart attack or stroke should ...
September 4, 2018 — Prevencio Inc. announced new data demonstrating its HART PAD test accurately diagnoses peripheral ...
August 31, 2018 — A weight loss drug does not increase cardiovascular events, according to late breaking results from ...
August 31, 2018 — Use of an oral anticoagulant in medically ill patients for 45 days following hospital discharge ...
August 30, 2018 — At the 2018 European Society of Cardiology (ESC) Congress, cardiovascular technology startup Maisense ...
August 29, 2018 — Philips announced that the European Society of Cardiology (ESC) has incorporated instantaneous wave ...
August 28, 2018 — Medtronic plc announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved ...
August 27, 2018 — Blood pressure and cholesterol-lowering drugs continue to improve survival in patients with hypertensi ...
August 27, 2018 — Acarix AB’s ultra-sensitive acoustic CADScor System for coronary artery disease risk assessment will ...
September 14, 2018